Aim To analyze the clinical patterns of new‐onset inflammatory arthritis after COVID‐19
vaccination among patients without pre‐existing rheumatic or autoimmune diseases …

Abstract Background The Pfizer BioNTech COVID-19 vaccine was the first to receive
emergency authorization and approval from the FDA. Therefore, it is preferred by most …

Background The pathogenesis of SIRVA is incompletely understood, but it is postulated to
be an immune-mediated inflammatory response to a vaccine antigen, leading to shoulder …

Objective The global fight against COVID-19 has required mass vaccination clinics as well
as mass recruitment of personnel, including many who may not regularly administer …

Background Shoulder injury related to vaccine administration (SIRVA) occurs when an
intramuscular deltoid injection is administered into the shoulder joint. This observational …

Background Current recommendations for needle length and vaccination site for
intramuscular deltoid vaccinations are backed by minimal data. Aim To determine the ideal …

[Purpose] To present the dramatic improvement in posture, radiographic parameters and the
alleviation of neck and severe shoulder pain related to shoulder injury associated with …

Vaccination against mRNA SARS-CoV-2 has been administered on a very large scale and
various side effects have been described. The increased risk of myopericarditis is known …

Shoulder injury related to vaccine administration (SIRVA) has been frequently reported
adverse event following COVID-19 vaccination. Multiple studies have reported various …

La pandemia a causa de la enfermedad por coronavirus (COVID-19 provocada por el virus
SARS-CoV-2 trajo como consecuencia transformaciones en el cambio de estilo de vida …